Pharmacists Emerge as Critical Partners in Multiple Sclerosis B-Cell Therapy Management
• Pharmacists are taking on expanded roles in shared decision-making for multiple sclerosis treatment, helping patients navigate complex B-cell therapies and improving treatment adherence.
• Clinical pharmacists are actively collaborating with physicians to provide comprehensive patient education, monitor safety parameters, and manage adverse effects of MS treatments like ofatumumab and ocrelizumab.
• Specialty pharmacists are instrumental in overcoming treatment barriers by managing prior authorizations, coordinating care across multiple conditions, and ensuring proper documentation for insurance coverage.
Inquis Medical Completes Enrollment in Pivotal Trial of Aventus Thrombectomy System for Pulmonary Embolism
• Inquis Medical has completed enrollment in its AVENTUS Clinical Trial, a pivotal IDE trial for the Aventus Thrombectomy System, designed to treat pulmonary embolism (PE).
• The trial enrolled 130 patients with intermediate-risk PE across more than 20 clinical sites in the United States.
• The Aventus system features streamlined blood return and directional aspiration, potentially offering a more efficient thrombectomy solution.
• The completion of enrollment marks a significant step toward a new treatment option for pulmonary embolism, addressing limitations of current procedures.
© Copyright 2025. All Rights Reserved by MedPath